Nucleus (Biotechnology)
Nucleus (Biotechnology) valuation and funding history | Last updated: January 30, 2025 | 5 funding rounds
Current Valuation
N/A
As of January 30, 2025
Total Funding Raised
$31.5M
Across 5 rounds
Last Round
Early Stage VC
$14.0M
Last Funding
Jan 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| N/A | Unknown | Undisclosed | N/A | - |
| N/A | Unknown | Undisclosed | N/A | - |
| N/A | Unknown | Undisclosed | N/A | - |
| N/A | Unknown | Undisclosed | N/A | - |
| N/A | Unknown | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Nucleus (Biotechnology) is currently valued at N/A as of January 30, 2025. The company has raised a total of $31.5M in funding across 5 funding rounds.
Explore More Data
Detailed analysis for Nucleus (Biotechnology)
What is Nucleus (Biotechnology) Worth in 2026?
Nucleus (Biotechnology) is a leading private company in the technology sector. Track Nucleus (Biotechnology)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Nucleus (Biotechnology) Valuation is Determined
Private company valuations like Nucleus (Biotechnology)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.